scholarly journals Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation

2016 ◽  
pp. 269 ◽  
Author(s):  
Ernst Noordraven ◽  
Andre Wierdsma ◽  
Peter Blanken ◽  
Anthony Bloemendaal ◽  
Cornelis Mulder
Keyword(s):  
Psychotic Disorders ◽  
Medication Compliance ◽  
Treatment Motivation ◽  
Depot Medication

scholarly journals FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN TERJADINYA KEKAMBUHAN PADA PENDERITA GANGGUAN JIWA DI WILAYAH KERJA PUSKESMAS SUNGAI DAREH KABUPATEN DHARMASRAYA

2018 ◽  
Vol 5 (1) ◽  
pp. 73-79
Author(s):  
Yuli Permata Sari ◽  
Vivi Nofita Sapitri ◽  
Yaslina Yaslina
Keyword(s):  
Mental Disorders ◽  
Family Support ◽  
Psychotic Disorders ◽  
Medication Compliance ◽  
P Value ◽  
Research Association ◽  
Drug Adherence ◽  
Thought Processes ◽  
Health Officer ◽  
Work Area

Mental disorders are a group of psychotic disorders, with a basic disorder of personality, a distinctive distortion of thought processes. Based on WHO data in 2015 the prevalence of mental disorders is 465 million in the world. Civil Registry Agency (BPS) 2015, the prevalence of people with mental disorders Indonesia reached 15.3% of the 259.9 million inhabitants of Indonesia. Based on data from Health Research Association (RISKESDAS) West Sumatera Province in 2015 mentions the prevalence of mental disorders 1.9 per mile. In the working area of ​​Puskesmas Sungai Dareh Dharmasraya district mental disorders increase annually where during the year 2015 is about 47 people, and in 2016 about 49 people. The purpose of this study is to determine "Factors associated with the occurrence of recurrence in people with mental disorders in the Work Area Puskesmas River Dareh Dharmasraya Regency Year 2017. This research method using descriptive analytic methods and methods Crosecsional study. The sample in this study were 40 respondents. This study was conducted on March 1 to 10, 2018. The result of medication compliance statistic test obtained p value = 0,000 (p <α), family support obtained p value = 0.001 (p <α), health officer support obtained p value = 0.000 (p <α) it can be concluded the existence of drug adherence compliance factor factor, family support and health officer support with the occurrence of recurrence in people with mental disorders in the Work Area Puskesmas River Dareh Dharmasraya Regency in 2017. It is suggested to the researchers then can research in different places, more samples, and conducted more in-depth research such as research with guided interviews.  

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders

2006 ◽  
Vol 187 (2) ◽  
pp. 229-236 ◽  
Author(s):  
Birgit Janssen ◽  
Wolfgang Gaebel ◽  
Martin Haerter ◽  
F. Komaharadi ◽  
Birgit Lindel ◽  
...  
Keyword(s):  
Inpatient Treatment ◽  
Psychotic Disorders ◽  
Medication Compliance ◽  
Factors Influencing

The link between cannabis use and psychosis: furthering the debate

2002 ◽  
Vol 33 (1) ◽  
pp. 3-6 ◽  
Author(s):  
LOUISA DEGENHARDT
Keyword(s):  
Substance Use ◽  
Psychotic Disorders ◽  
Medication Compliance ◽  
Cannabis Use ◽  
Psychotic Symptoms ◽  
The Past ◽  
Significant Disability ◽  
High Doses ◽  
Persons With Schizophrenia ◽  
Psychotomimetic Effects

The issue of whether an association exists between cannabis and psychosis exists, and why, has received considerable attention in recent years (Hall, 1998; Mueser et al. 1998; Blanchard et al. 2000; Degenhardt & Hall, 2002). There are probably a number of reasons for the sustained interest. First, psychotic disorders such as schizophrenia are often chronic or recurring (Mason et al. 1996), are associated with significant disability (Keith et al. 1991) and they place a considerable burden upon the community at large (Hall et al. 1985; Knapp, 1997). Secondly, over the past few decades, high rates of cannabis use and use disorders have been observed among persons with schizophrenia and other psychoses (Barbee et al. 1989; Fowler et al. 1998), suggesting the possibility that cannabis use may be causally related to psychotic disorders. Thirdly, given what is known about the psychotomimetic effects of cannabis (Hall et al. 2001), it is plausible that high doses of cannabis may produce psychotic symptoms. Finally, clinical research with persons with psychotic disorders has found that problematical substance use is correlated with a range of negative outcomes including relapse, rehospitalization, poor medication compliance, poorer social functioning and increased treatment costs (Salyers & Mueser, 2001), suggesting drug use may be related to worsened clinical outcomes.

scholarly journals The subjective concept of morbidity: its assessment and connection with the motivation for treatment in persons who underwent psychosis

2020 ◽  
pp. 73-79
Author(s):  
N. B. Lutova ◽  
M. Y. Sorokin ◽  
O. V. Makarevich ◽  
V. D. Wied
Keyword(s):  
Negative Symptoms ◽  
Medication Compliance ◽  
Subjective Assessment ◽  
Russian Language ◽  
Subjective Perception ◽  
Treatment Motivation ◽  
Subjective Meaning ◽  
Icd 10 ◽  
Compensatory Reactions ◽  
Motivation For Treatment

Medication compliance and motivation for treatment, as adaptive- compensatory reactions of patients to the awareness of the fact of their own ill- being, are based on subjective perception of the disorder. To date, there is a shortage of objective methods for assessing the subjective concept of morbidity in psychotic patients.160 inpatients with psychosis in anamnesis were examined: nosologically according ICD-10 80%—F2, 11%—F3, 9%—F0. A self-questionnaire was adapted to the Russian language for determining the subjective meaning and significance of psychosis (Susi). The results of its internal and external (when compared with data on the severity of productive and negative symptoms, subjective assessment of the severity of the condition and treatment motivation of patients) validation are presented.Conclusions. The applicability of the concept of subjective morbidity in patients with mental disorders is shown. The role of the subjective attitude to the disease in case of its perception as a destructive life event is associated in patients with a violation of the structure of motivation for treatment. On the contrary, the ability of patients to form a subjective meaning of the disease can be considered as a guarantee of more intense therapeutic motivation.

The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study

2007 ◽  
Vol 37 (7) ◽  
pp. 927-934 ◽  
Author(s):  
LOUISA DEGENHARDT ◽  
CHRIS TENNANT ◽  
STUART GILMOUR ◽  
DAVID SCHOFIELD ◽  
LOUISE NASH ◽  
...  
Keyword(s):  
Prospective Study ◽  
Psychotic Disorders ◽  
Temporal Dynamics ◽  
Medication Compliance ◽  
Cannabis Use ◽  
Regression Methods ◽  
Symptoms Of Depression ◽  
Temporal Relationships ◽  
Persons With Schizophrenia ◽  
A Prospective Study

Background. The aim was to examine the temporal relationships over 10 months between cannabis use and symptoms of psychosis and depression in people with schizophrenia and related disorders. The design was a prospective study of 101 patients with schizophrenia and related disorders who were assessed monthly over 10 months on medication compliance, cannabis and other drug use, symptoms of depression and symptoms of psychosis.Method. Linear regression methods to assess relationships between cannabis use and symptoms of psychosis and depression while adjusting for serial dependence, medication compliance and other demographic and clinical variables.Results. Cannabis use predicted a small but statistically significant increase in symptoms of psychosis, but not depression, after controlling for other differences between cannabis users and non-users. Symptoms of depression and psychosis did not predict cannabis use.Conclusion. Continued cannabis use by persons with schizophrenia predicts a small increase in psychotic symptom severity but not vice versa.

Psychosocial Risks and Management for Children and Adolescents With 22q11.2 Deletion Syndrome

2019 ◽  
Vol 4 (4) ◽  
pp. 633-640 ◽  
Author(s):  
Canice E. Crerand ◽  
Ari N. Rabkin
Keyword(s):  
Cognitive Abilities ◽  
Psychotic Disorders ◽  
Developmental Stages ◽  
Early Adulthood ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion ◽  
Psychosocial Risks ◽  
Empirically Supported ◽  
Specific Education

Purpose This article reviews the psychosocial risks associated with 22q11.2 deletion syndrome, a relatively common genetic condition associated with a range of physical and psychiatric problems. Risks associated with developmental stages from infancy through adolescence and early adulthood are described, including developmental, learning, and intellectual disabilities as well as psychiatric disorders including anxiety, mood, and psychotic disorders. Other risks related to coping with health problems and related treatments are also detailed for both affected individuals and their families. Conclusion The article ends with strategies for addressing psychosocial risks including provision of condition-specific education, enhancement of social support, routine assessment of cognitive abilities, regular mental health screening, and referrals for empirically supported psychiatric and psychological treatments.

Assessing Mental and Behavioral Disorder Impairment: Overview of Sixth Edition Approaches

2008 ◽  
Vol 13 (6) ◽  
pp. 1-7
Author(s):  
Norma Leclair ◽  
Steve Leclair ◽  
Robert Barth
Keyword(s):  
Mental Disorders ◽  
Behavioral Disorders ◽  
Psychotic Disorders ◽  
Behavioral Disorder ◽  
Behavioral Impairment ◽  
Central Nervous System Damage ◽  
Brain Functioning ◽  
Sixth Edition ◽  
Diagnostic And Statistical Manual ◽  
Mental And Behavioral Disorders

Abstract Chapter 14, Mental and Behavioral Disorders, in the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Sixth Edition, defines a process for assessing permanent impairment, including providing numeric ratings, for persons with specific mental and behavioral disorders. These mental disorders are limited to mood disorders, anxiety disorders, and psychotic disorders, and this chapter focuses on the evaluation of brain functioning and its effects on behavior in the absence of evident traumatic or disease-related objective central nervous system damage. This article poses and answers questions about the sixth edition. For example, this is the first since the second edition (1984) that provides a numeric impairment rating, and this edition establishes a standard, uniform template to translate human trauma or disease into a percentage of whole person impairment. Persons who conduct independent mental and behavioral evaluation using this chapter should be trained in psychiatry or psychology; other users should be experienced in psychiatric or psychological evaluations and should have expertise in the diagnosis and treatment of mental and behavioral disorders. The critical first step in determining a mental or behavioral impairment rating is to document the existence of a definitive diagnosis based on the current edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders. The article also enumerates the psychiatric disorders that are considered ratable in the sixth edition, addresses use of the sixth edition during independent medical evaluations, and answers additional questions.

Errata

2008 ◽  
Vol 13 (2) ◽  
pp. 5-5
Keyword(s):  
Psychotic Disorders ◽  
Pain Syndrome ◽  
Vestibular Disorders ◽  
Loss Of Function ◽  
Sixth Edition ◽  
Neurologic Disorders ◽  
Upper And Lower Extremities ◽  
Impairment Ratings ◽  
Extensive List ◽  
Mental And Behavioral Disorders

Abstract Although most chapters in the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Sixth Edition, instruct evaluators to perform impairment ratings by first assigning a diagnosis-based class and then assigning a grade within that class, Chapter 13, The Central and Peripheral Nervous System, continues to use a methodology similar to that of the fifth edition. The latter was criticized for duplicating materials that were presented in other chapters and for producing different ratings, so the revision of Chapter 13 attempts to maintain consistency between this chapter and those that address mental and behavioral disorders, loss of function in upper and lower extremities, loss of bowel control, and bladder and sexual function. A table titled Summary of Chapters Used to Rate Various Neurologic Disorders directs physicians to the relevant chapters (ie, instead of Chapter 13) to consult in rating neurologic disorders; the extensive list of conditions that should be addressed in other chapters includes but is not limited to radiculopathy, plexus injuries and other plexopathies, focal neuropathy, complex regional pain syndrome, visual and vestibular disorders, and a range of primary mood, anxiety, and psychotic disorders. The article comments in detail on sections of this chapter, identifies changes in the sixth edition, and provide guidance regarding use of the new edition, resulting in less duplication and greater consistency.

Sign in / Sign up

Export Citation Format

Share Document